
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Physiol.
Sec. Computational Physiology and Medicine
Volume 16 - 2025 | doi: 10.3389/fphys.2025.1547117
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
The adequacy of hemodialysis (HD) in patients with end-stage renal disease is evaluated frequently by monitoring changes in blood urea concentrations multiple times between treatments. As monitoring of urea concentrations typically requires blood sampling, the development of sweat-sensing technology offers a possible less-invasive alternative to repeated venipuncture. Moreover, this innovative technology could enable personalized treatment in a home-based setting. However, the clinical interpretation of sweat monitoring is hampered by the limited literature on the correlation between urea concentrations in sweat and blood. This study introduces a pioneering approach to estimate blood urea concentrations using sweat urea concentration values as input. To simulate the complex transport mechanisms of urea from blood to sweat, a novel pharmacokinetic transport model is proposed. Such a transport model, together with a double-loop optimization strategy from our previous work, was employed for patient-specific estimation of blood urea concentration. 32 patient samples of paired sweat and blood urea concentrations, collected both before and after HD, were used to validate the model. This resulted in an excellent Pearson correlation coefficient (0.98, 95%CI: 0.95-0.99) and a clinically irrelevant bias (-0.181 mmol/L before and -0.005 mmol/L after HD). This model enabled the accurate estimation of blood urea concentrations from sweat measurements. By accurately estimating blood urea concentrations from sweat measurements, our model enables non-invasive and more frequent assessments of dialysis adequacy in ESRD patients. This approach could facilitate home-based and patient-friendly dialysis management, enhancing patient comfort while enabling more personalized treatment across diverse clinical settings.
Keywords: Kidney failure, end-stage renal disease, Patient monitoring, Pharmacokinetic modeling, inverse modeling
Received: 17 Dec 2024; Accepted: 03 Mar 2025.
Copyright: © 2025 Yin, Adelaars, Peri, Pelssers, Den Toonder, Bouwman, Van De Kerkhof and Mischi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Xiaoyu Yin, Eindhoven University of Technology, Eindhoven, Netherlands
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.